Patients were assigned randomly to receive intravenous infusions of infliximab @ mg/kg at weeks @ , @ , @ , and @ plus daily oral placebo capsules ; oral azathioprine @ mg/kg daily plus placebo infusions on the infliximab schedule ; or combination therapy with the @ drugs .